Copper as the Target for Anticancer Nanomedicine.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201800147
- By:
- Publication type:
- Article
Works matching IS 23663987 AND DT 2019 AND VI 2 AND IP 5
Results: 10
1
2
Tailor‐Made Core‐Multishell Nanocarriers for the Delivery of Cationic Analgesics to Inflamed Tissue.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201900007
- By:
- Publication type:
- Article
3
Cowpea Mosaic Virus Promotes Anti‐Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201900003
- By:
- Publication type:
- Article
4
Masthead (Adv. Therap. 5/2019).
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201970010
- Publication type:
- Article
5
Nonlinear Supramolecular Polymers for Therapeutic Applications.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201900050
- By:
- Publication type:
- Article
6
An NIR‐Fluorophore‐Based Inhibitor of SOD1 Induces Apoptosis by Targeting Transcription Cofactor PC4.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201800148
- By:
- Publication type:
- Article
7
Personalized Therapy: An NIR‐Fluorophore‐Based Inhibitor of SOD1 Induces Apoptosis by Targeting Transcription Cofactor PC4 (Adv. Therap. 5/2019).
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201970009
- By:
- Publication type:
- Article
8
Naturally Occurring Bioactive Compound‐Derived Nanoparticles for Biomedical Applications.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201800146
- By:
- Publication type:
- Article
9
Supramolecular Nanogel‐Based Universal Drug Carriers Formed by "Soft–Hard" Co‐Assembly: Accurate Cancer Diagnosis and Hypoxia‐Activated Cancer Therapy.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201800140
- By:
- Publication type:
- Article
10
Chitooligosaccharide Biguanide Repairs Islet β‐Cell Dysfunction by Activating the IRS‐2/PI3K/Akt Signaling Pathway in Type 2 Diabetic Rats.
- Published in:
- Advanced Therapeutics, 2019, v. 2, n. 5, p. N.PAG, doi. 10.1002/adtp.201800136
- By:
- Publication type:
- Article